Endo Pharmaceuticals: A Global Leader in Specialty Healthcare

As a leading pharmaceutical company, Endo Pharmaceuticals is dedicated to developing and delivering high-value branded products that meet the unmet needs of patients. With its global presence and commitment to improving patient lives, Endo Pharmaceuticals has established itself as a key player in the industry.

The company's success can be attributed to its focus on strategic initiatives and critical issues. The strategy meetings, held twice a month, bring together directors and senior executives to deliberate on matters related to management. These meetings are crucial in ensuring that the company stays focused on its goals and objectives.

Endo Pharmaceuticals' Board of Directors is composed of six members, including two outside directors. In addition to regular monthly meetings, the board also holds extraordinary meetings as necessary to address critical issues. The board plays a vital role in overseeing the execution of directors' duties and making decisions on basic policies related to management.

The company has a strong commitment to audit and compliance. It has selected three outside auditors who attend every meeting of the Board of Directors, ensuring that the company's financial statements are accurate and compliant with regulatory requirements.

Endo Pharmaceuticals is part of Endo International plc, a global specialty healthcare company focused on improving patients' lives while creating value. The company operates through its subsidiaries, including Qualitest, AMS, Paladin Labs, and SOMAR. These companies work together to develop, manufacture, market, and distribute high-quality products across key market segments in the United States, Canada, and Mexico.

In conclusion, Endo Pharmaceuticals is a global leader in specialty healthcare that is dedicated to improving patient lives while creating value. Its commitment to strategic initiatives, audit, and compliance has enabled it to establish itself as a trusted partner in the industry.

Bidness etc endo pharmaceuticals